Investigative Urology - Results from #6780

Angiogenin as a molecular target for the treatment of prostate cancer - Abstract July 27, 2011

Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression - Abstract July 27, 2011

Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness - Abstract July 27, 2011

Genome-wide association study identifies new prostate cancer susceptibility loci - Abstract July 27, 2011

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas - Abstract July 27, 2011

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study - Abstract July 27, 2011

Investigation of phosphoprotein signatures of archived prostate cancer tissue specimens via proteomic analysis - Abstract July 26, 2011

Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families - Abstract July 25, 2011

Clusterin inhibition using OGX-011 synergistically enhances Hsp90 inhibitor activity by suppressing the heat shock response in castrate resistant prostate cancer - Abstract July 25, 2011

Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells - Abstract July 22, 2011

Do androgens control the uptake of (18)F-FDG, (11)C-choline and (11)C-acetate in human prostate cancer cell lines? - Abstract July 22, 2011

Comparison of circulating microRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer - Abstract July 21, 2011

Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer - Abstract July 21, 2011

Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continues - Abstract July 21, 2011

Lupeol, a novel androgen receptor inhibitor: Implications in prostate cancer therapy - Abstract July 19, 2011

Resveratrol and prostate cancer: Promising role for microRNAs - Abstract July 19, 2011

shRNA targeting PLCε inhibits bladder cancer cell growth in vitro and in vivo - Abstract July 19, 2011

MiR-34a chemo-sensitizes bladder cancer cells to cisplatin treatment regardless of P53-Rb pathway status - Abstract July 18, 2011

Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer - Abstract July 15, 2011

Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer - Abstract July 15, 2011

Page 340 of 346